"Reading the Paper" Lynne Crumpacker
Now Available! CCO Hepatology inPractice™
This special edition includes all the pivotal phase III studies of the HCV protease inhibitors, with a range of commentaries exploring key aspects of the use of these agents, plus Capsule Summaries of each study and downloadable slidesets.
Topics include:
- Following response-guided therapy guidelines with boceprevir and telaprevir
- Understanding futility rules and their importance
- Outcomes and management of anemia
- Strategies for managing telaprevir rash and anorectal symptoms
- Using boceprevir and telaprevir in patients with advanced fibrosis or cirrhosis
- Effect of telaprevir on cyclosporine and tacrolimus pharmacokinetics
- Antiviral activity with telaprevir in patients with genotype 2 or 3 HCV
- Evaluation of HBV screening cost effectiveness
*Free Registration Required-Register Here
No comments:
Post a Comment